Suppliers / Bespak Hc

Bespak Hc

United Kingdom Updated 9 July 2026

Bespak Hc is a finished-dose manufacturer based in United Kingdom. It appears in 3 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with EDE (AE), ARCSA (EC) and INVIMA (CO). Its GMP standing is certified by MHRA (UK), MFDS (Korea) and ANVISA (Brazil), among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 26 November 2020 as VAI.

0
active US DMFs
0
valid CEPs
3
registered plants 1 with an FDA FEI number
3
filings across 3 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
6 of 6 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 26 November 2020 VAI US FDA
  • 10 November 2017 VAI US FDA
  • 15 January 2016 VAI US FDA
  • 7 March 2014 NAI US FDA
  • 9 September 2011 VAI US FDA
  • 28 August 2009 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Holmes Chapel, United Arab Emirates Not on file
CREWE, United Kingdom Not on file
United Kingdom, United Kingdom 3001621739

Filings and GMP by regulator

Regulator Filings GMP certificates
EDE (AE) 1 None
ARCSA (EC) 1 None
INVIMA (CO) 1 None
MHRA (UK) None 4
MFDS (Korea) None 2
ANVISA (Brazil) None 2
NCELS (KZ) None 1

Questions about Bespak Hc

Does Bespak Hc hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Bespak Hc. It does have 3 filings with 3 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Bespak Hc FDA-registered?
One site operated by Bespak Hc carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Bespak Hc's last inspection go?
The most recent inspection on record closed on 26 November 2020 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 6 inspections are on file.
Where does Bespak Hc manufacture?
3 registered sites are on record, in United Arab Emirates and United Kingdom (Holmes Chapel, Crewe and United Kingdom). Every site is listed on this page with the register it came from.
Which regulators recognise Bespak Hc's GMP?
Current GMP certificates are on record from MHRA (UK), MFDS (Korea), ANVISA (Brazil) and NCELS (KZ). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Bespak Hc comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 26 November 2020.

Comparable suppliers

ALMAC Pharma Services also in United Kingdom Almac Sciences also in United Kingdom AstraZeneca UK also in United Kingdom Bard Pharmaceuticals also in United Kingdom Bell, Sons & Co (Druggists) also in United Kingdom

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates